These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus. Crasto W; Jarvis J; Hackett E; Nayyar V; McNally PG; Davies MJ; Lawrence IG Postgrad Med J; 2009 Apr; 85(1002):219-22. PubMed ID: 19417173 [TBL] [Abstract][Full Text] [Related]
43. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459 [TBL] [Abstract][Full Text] [Related]
49. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Siebenhofer A; Jeitler K; Berghold A; Horvath K; Pieber TR Diabet Med; 2009 Mar; 26(3):311-2; author reply 312-3. PubMed ID: 19317829 [No Abstract] [Full Text] [Related]
50. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy. Bruttomesso D; Costa S; Baritussio A Diabetes Metab Res Rev; 2009 Feb; 25(2):99-111. PubMed ID: 19172576 [TBL] [Abstract][Full Text] [Related]
51. The current status of insulin pump therapy of diabetes mellitus. Hill LL Resid Staff Physician; 1982 Dec; 28(12):15s-7s, 21s-4s, 29s-31s. PubMed ID: 10258877 [No Abstract] [Full Text] [Related]
52. MEASURE IT, IMPROVE IT: the Safer Patients Initiative and quality improvement in subcutaneous insulin therapy for hospital in-patients. Rushmer R; Voigt D Diabet Med; 2008 Aug; 25(8):960-7. PubMed ID: 18959610 [TBL] [Abstract][Full Text] [Related]
53. Simultaneous use of two external subcutaneous pumps delivering insulin and SYMLIN: use of a double-pump system. Schorr AB; Ofan R J Diabetes Sci Technol; 2012 Nov; 6(6):1507-8. PubMed ID: 23294799 [No Abstract] [Full Text] [Related]
54. Insulin pumps buy time until transplant therapy arrives. Morrow T Manag Care; 2004 Mar; 13(3):52-3. PubMed ID: 15074158 [No Abstract] [Full Text] [Related]
55. Proceedings of a conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. March 21-25, 1983, Santa Ynez, California. Diabetes; 1985 Aug; 34 Suppl 3():1-91. PubMed ID: 4018419 [No Abstract] [Full Text] [Related]
56. A new approach to diabetic control: fuzzy logic and insulin pump technology. Grant P Med Eng Phys; 2007 Sep; 29(7):824-7. PubMed ID: 17052939 [TBL] [Abstract][Full Text] [Related]
57. [Technical characteristics and principles of operation of an insulin pump in the treatment of diabetes mellitus]. Dedov II; Budiak LV Med Tekh; 1989; (2):35-42. PubMed ID: 2664414 [No Abstract] [Full Text] [Related]
58. Skipping the syringe: options for insulin. Johns Hopkins Med Lett Health After 50; 2006 Feb; 17(12):6. PubMed ID: 17115474 [No Abstract] [Full Text] [Related]
59. Proceedings of a conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. Introduction. The Kroc Collaborative Study Group. Diabetes; 1985 Aug; 34 Suppl 3():1-4. PubMed ID: 4018418 [No Abstract] [Full Text] [Related]